Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study
Nabil Seery, Sifat Sharmin, Vivien Li, Ai‐Lan Nguyen, Claire Meaton, Roberts Atvars, Nicola Taylor, Kelsey Tunnell, John P. Carey, Mark Marriott, Katherine Buzzard, Izanne Roos, Chris Dwyer, Josephine Baker, Lisa Taylor, Kymble Spriggs, Trevor J. Kilpatrick, Tomáš Kalinčík, Mastura Monif
Topics & Concepts
MedicineOcrelizumabInternal medicineOdds ratioRetrospective cohort studyMultiple sclerosisCohort studyUnivariate analysisLogistic regressionCohortImmunologyMultivariate analysisRituximabLymphomaMultiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersRheumatoid Arthritis Research and Therapies